WC
AGN

Weil Company’s Allergan plc AGN Stock Holding History

Weil Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-105
Closed -$18K – 386
2019
Q3 		$18K Buy
+105
New +$17.1K 0.01% 251
2019
Q2 		– Sell
-8,905
Closed -$1.3M – 110
2019
Q1 		$1.3M Sell
8,905
-800
-8% -$116K 1.09% 25
2018
Q4 		$1.3M Sell
9,705
-376
-4% -$61.6K 1.17% 26
2018
Q3 		$1.85M Sell
10,081
-1,250
-11% -$230K 1.53% 18
2018
Q2 		$1.89M Buy
11,331
+3,720
+49% +$597K 1.6% 15
2018
Q1 		$1.28M Buy
7,611
+730
+11% +$122K 1.2% 27
2017
Q4 		$1.13M Buy
+6,881
New +$1.23M 1.03% 25

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Weil Company's AGN Position: Q4 2019 in Review

Weil Company sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 105 shares — an estimated $18K sold.

Weil Company first reported a position in AGN in Q4 2017 and held it in 7 quarters. The position peaked at $1.89M in Q2 2018. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Weil Company reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Weil Company sold 105 Allergan plc shares in Q4 2019, an estimated $18K.
  • Weil Company first reported a position in Allergan plc in Q4 2017 and held it in 7 quarters.
  • Weil Company's Allergan plc position peaked at $1.89M in Q2 2018.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.